Application of MR functional sequence DKI and DCE in diagnosis and pre-treatment evaluation of gynecological tumors

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300073225

Enrollment

Unknown

Registered

2023-07-04

Start date

2022-02-17

Completion date

Unknown

Last updated

2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer, endometrial cancer and ovarian cancer

Interventions

Gold Standard:Pathological diagnosis of endometrial cancer, cervical cancer or ovarian cancer

Index test:Dynamic Enhanced MRI (DCE-MRI)

Diffusion Kurtosis Imaging (DKI)

sensitivity

specificity

accuracy

positive predictive value

negative predictive value

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients underwent surgical resection (interval between surgical resection and imaging examination < 2 weeks) and were pathologically confirmed as endometrial cancer, cervical cancer or ovarian cancer.

Exclusion criteria

Exclusion criteria: 1) Previous history of chemotherapy and/or radiotherapy; 2) No surgical resection; 3) The interval between surgical resection and imaging examination was > 2 weeks; 4) Obvious artifacts; 5) Contraindications to MRI scanning.

Design outcomes

Primary

Measure	Time frame
Parameters of MR functional sequence;Sensitivity;Specificity ;Positive predicative value;Negative predictive value;Accuracy ;	—

Countries

China

Contacts

Public ContactXiaohui Duan

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University

duanxh5@mail.sysu.edu.cn+86 135 1276 2365

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026